GP

GPC BIOTECH AG

  • CIK: 0001117629
  • EIN: 00-0000000
  • Business address: FRAUNHOFERSTRABE 20, 82152 MUNCHEN, GERMANY, Ghana, 00000

Information

  • Mailing address
  • Phone
    N/A
  • State location
    Ghana
  • State of incorporation
    N/A
  • Fiscal year end
    N/A
  • SIC
    2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
  • Filings
    N/A

About GPC BIOTECH AG

GPC BIOTECH AG (CIK: 0001117629) is an American company incorporated in the state of Ghana. Head office is located at FRAUNHOFERSTRABE 20, 82152 MUNCHEN, GERMANY, Ghana, 00000. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. GPC BIOTECH AG is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by GPC BIOTECH AG

Filings Format Description Filed/Effective File/Film Number
15F-12G Document

Notice of termination of a foreign private issuer’s registration of a class of securities under Section 12(g)

Acc-no: 0001193125-09-058681 (34 Act) Size: 51 KB		 Mar-19-2009

000-50825

09693857
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001193125-09-055422 (33 Act) Size: 16 KB		 Mar-16-2009

333-117098

09684521
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001193125-09-055407 (33 Act) Size: 15 KB		 Mar-16-2009

333-136932

09684449
25 Document

Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange

Acc-no: 0001193125-09-041010 (34 Act) Size: 9 KB		 Feb-27-2009

000-50825

09643334
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001181431-09-010576 (34 Act) Size: 24 KB		 Feb-23-2009

000-50825

09627587
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-08-239006 (34 Act) Size: 208 KB		 Nov-19-2008

000-50825

081199944
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-08-238322 (34 Act) Size: 224 KB		 Nov-18-2008

000-50825

081197416
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-08-236567 (34 Act) Size: 42 KB		 Nov-14-2008

000-50825

081189568
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001181431-08-054001 (34 Act) Size: 17 KB		 Sep-22-2008

000-50825

081082040
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-08-183503 (34 Act) Size: 202 KB		 Aug-25-2008

000-50825

081036672
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-08-177824 (34 Act) Size: 187 KB		 Aug-14-2008

000-50825

081016673
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001181431-08-048034 (34 Act) Size: 18 KB		 Aug-13-2008

000-50825

081012427
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-08-175731 (34 Act) Size: 197 KB		 Aug-13-2008

000-50825

081011743
CT ORDER Document Acc-no: 9999999997-08-034259 (34 Act) Size: 18 KB Jul-30-2008

000-50825

08979469
20-F Document

Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d)

Acc-no: 0001193125-08-144123 (34 Act) Size: 2143 KB		 Jun-30-2008

000-50825

08926444
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-08-072475 (34 Act) Size: 24785 KB		 Apr-01-2008

000-50825

08730274
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001193125-08-072228 (34 Act) Size: 160 KB		 Apr-01-2008

000-50825

08729045
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001157523-08-001685 (34 Act) Size: 25 KB		 Feb-25-2008

000-50825

08639549
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001116502-08-000133 (34 Act) Size: 219 KB		 Jan-31-2008

005-80162

08563782
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001181431-07-073219 (34 Act) Size: 18 KB		 Dec-05-2007

000-50825

071285626

Recent 20 filings. View all GPC BIOTECH AG filings

Reviews

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Frequently Asked Questions

Tags:

  • GPC BIOTECH AG overview
  • GPC BIOTECH AG job
  • GPC BIOTECH AG stock
  • GPC BIOTECH AG ownership
  • GPC BIOTECH AG CEO
  • GPC BIOTECH AG documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Contineum Therapeutics, Inc.
Update: Mar 16, 2024
Cuprina Holdings (Cayman) LTD
Update: Mar 08, 2024
APRINOIA Therapeutics Inc.
Update: Jan 27, 2024
Zhengye Biotechnology Holding Ltd
Update: Jan 10, 2024
Alto Neuroscience, Inc.
Update: Nov 28, 2023
Mural Oncology plc
Update: Nov 02, 2023

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 4969 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3338 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 1752 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 2873 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 3056 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 3657 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 2326 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 4631 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 2929 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by